News Focus
News Focus
Replies to #97719 on Biotech Values
icon url

MotionMan

06/23/10 2:06 AM

#97723 RE: DewDiligence #97719

MNTA: wasn't the Palo Alto Group once a top shareholder? Do they no longer have significant amount of shares? Just wondering...
icon url

DewDiligence

09/08/10 3:02 PM

#103754 RE: DewDiligence #97719

MNTA Major Shareholders

[Updated for Oppenheimer filing.]


The table below shows all shareholders who file Form 13G and
all insiders with a 1%+ stake. The percentages in the table are
based on 49.1M diluted shares (#msg-42163809), and hence they
differ from the percentages shown in SEC filings. Insider holdings
include restricted stock and options, whether or not vested.


Shares Stake

Oppenheimer 5,003,200† 10.2%
Novartis 4,708,679 9.6%
T Rowe Price 4,520,273 9.2%
BlackRock Inc. 2,782,260 5.7%
Visium Asset Mgmt 2,307,096 4.7%
Samana Capital 2,048,303 4.2%
Craig Wheeler (CEO) 1,145,469 2.4%
G. Venkataraman (SVP) 631,315 1.3%
R. Sasisekharan (Director) 507,344 1.0%

†As of 8/31/10 (from 13G filing 9/8/10).